Pricing Log in Create free account

OS Therapies Incorporated (OSTX) vs Verrica Pharmaceuticals Inc. (VRCA)

OS Therapies Incorporated and Verrica Pharmaceuticals Inc. are both Biotechnology companies. OS Therapies Incorporated and Verrica Pharmaceuticals Inc. are of similar size ($53.1M and $51.3M). OS Therapies Incorporated has the higher net margin (0.00% vs −102.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, OS Therapies Incorporated leads on 6 and Verrica Pharmaceuticals Inc. on 5.

Valuation

Metric OSTX VRCA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.26 9.40
P/B n/m 15.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 2.33 9.02
Earnings yield (107.07%) (51.86%) (32.88%)
Free cash flow yield (43.97%) (19.81%) (23.13%)

Profitability

Metric OSTX VRCA Biotechnology median
Gross margin — 85.89% 68.51%
Operating margin 0.00% (93.59%) 0.00%
Net margin 0.00% (102.84%) 0.00%
Free cash flow margin 0.00% (44.02%) 0.00%
Return on equity 1,129.52% 473.29% (51.96%)
Return on assets (389.65%) (83.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OSTX VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 6.76%
EPS growth (last fiscal year) 23.32% 88.65% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric OSTX VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 0.18 1.45 4.97
Net debt to EBITDA 0.01 2.59 1.01

Dividend

Metric OSTX VRCA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OSTX VRCA Biotechnology median
Market cap 51.28m 53.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack